Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease.
Neuroinflammation has been implicated in the pathology of Alzheimer's disease (AD) for decades. Still it has not been fully understood when and how inflammation arises in the course of AD. Whether inflammation is an underling cause or a resulting condition in AD remains unresolved. Mounting evidence indicates that microglial activation contributes to neuronal damage in neurodegenerative diseases. However, also beneficial aspects of microglial activation have been identified. The purpose of this review is to highlight new insights into the detrimental and beneficial role of neuroinflammation in AD. It is our intention to focus on newer controversies in the field of microglia activation. Precisely, we want to shed light on whether neuroinflammation is associated to brain tissue damage and functional impairment or is there also a damage limiting activity. In regard to this, we discuss the limitations and the advantages of anti-inflammatory treatment options and identify what future implications might result from this underling neuroinflammation for AD therapy.
Krause
Daniela L
DL
Department of Psychiatry and Psychotherapy, Ludwig-Maximilians University Munich, Nussbaumstr. 7, 80336 Munich, Germany.
Müller
Norbert
N
Nat Neurosci. 2007 Nov;10(11):1387-94
17965659
Neuroreport. 1997 Jan 20;8(2):431-4
9080423
J Neurosci Res. 1997 Dec 15;50(6):937-45
9452008
Curr Mol Pharmacol. 2009 Jan;2(1):77-82
20021448
Neurobiol Dis. 2008 Dec;32(3):412-9
18786637
Pharmacol Rep. 2008 Sep-Oct;60(5):692-8
19066416
Neurology. 2000 Jun 13;54(11):2066-71
10851364
Nature. 2001 Nov 8;414(6860):212-6
11700559
Proc Natl Acad Sci U S A. 2004 May 25;101(21):8180-5
15141078
Neurobiol Aging. 2000 May-Jun;21(3):383-421
10858586
Neurology. 2008 May 6;70(19):1672-7
18458226
J Biol Chem. 1996 Dec 20;271(51):32714-21
8955104
Nat Med. 2004 Oct;10(10):1065-6
15448688
Stroke. 2001 Oct;32(10):2370-5
11588328
J Neurosci. 2005 Sep 7;25(36):8240-9
16148231
Nat Med. 2006 Sep;12(9):1005-15
16960575
Neurosci Lett. 1990 Oct 30;119(1):32-6
2097581
Neurochem Int. 2007 Jan;50(1):83-94
16959377
Nat Med. 2001 May;7(5):612-8
11329064
Ann N Y Acad Sci. 2000;924:132-5
11193789
Neurochem Int. 1995 Jul;27(1):119-37
7655344
Mol Cell Neurosci. 1999 Jan;13(1):57-68
10049531
Arch Neurol. 2001 Mar;58(3):487-92
11255454
Exp Gerontol. 2001 Jan;36(1):171-6
11162920
ASN Neuro. 2009 Nov 09;1(4):
19839939
Neurobiol Aging. 1999 May-Jun;20(3):305-13
10588578
Neurobiol Aging. 1996 Sep-Oct;17(5):801-8
8892355
J Neuropathol Exp Neurol. 2010 Feb;69(2):155-67
20084018
Neurology. 2008 Jan 1;70(1):17-24
18003940
J Neurosci. 1999 Feb 1;19(3):928-39
9920656
J Pharmacol Exp Ther. 2000 May;293(2):417-25
10773011
Am J Pathol. 1990 Aug;137(2):241-6
2117395
Am J Pathol. 2001 Apr;158(4):1345-54
11290552
Tijdschr Gerontol Geriatr. 2003 Feb;34(1):6-12
12629905
J Neuropathol Exp Neurol. 1996 Oct;55(10):1083-8
8858005
Nat Med. 2005 May;11(5):545-50
15834426
J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):85-8
15944180
Dement Geriatr Cogn Disord. 2008;25(3):278-86
18303264
Eur J Neurosci. 2001 Feb;13(3):569-75
11168565
Nat Neurosci. 2006 Feb;9(2):268-75
16415867
Exp Neurol. 1990 Oct;110(1):93-104
1698655
Neurology. 1999 Oct 22;53(7):1495-8
10534257
N Engl J Med. 2001 Nov 22;345(21):1515-21
11794217
Nat Rev Neurosci. 2007 Jan;8(1):57-69
17180163
Nature. 1998 Jan 1;391(6662):79-82
9422508
Exp Neurol. 1997 Apr;144(2):339-49
9168834
Neurosci Lett. 1995 Nov 24;200(3):187-90
9064608
J Neurochem. 1997 Feb;68(2):704-9
9003059
Brain Res. 1997 Nov 28;777(1-2):210-8
9449430
Neurology. 1997 May;48(5 Suppl 6):S35-41
9153159
FASEB J. 2004 Jun;18(9):998-1000
15084516
Int J Biochem Cell Biol. 1997 Mar;29(3):437-46
9202422
Nature. 1998 Jan 1;391(6662):82-6
9422509
Neurology. 1996 Aug;47(2):425-32
8757015
Curr Pharm Des. 2008;14(5):429-42
18289070
Braz J Med Biol Res. 2009 Nov;42(11):1002-14
19855900
J Biol Chem. 1997 Feb 7;272(6):3406-10
9013583
Neurosci Lett. 2009 Jan 30;450(2):122-6
19061939
J Biol Chem. 1996 Dec 27;271(52):33157-60
8969167
Glia. 2006 Apr 1;53(5):484-90
16369931
Glia. 2006 May;53(7):776-82
16534778
Curr Pharm Des. 2003;9(30):2541-51
14529552
Am J Pathol. 1999 Sep;155(3):995-1004
10487857
J Neurochem. 2009 Jul;110(2):469-85
19457088
Neuroscience. 1998 Nov;87(2):319-24
9740394
J Neurosci Res. 2005 Aug 1;81(3):302-13
15954124
Nat Rev Neurosci. 2003 Feb;4(2):103-12
12563281
Neurobiol Aging. 2001 Nov-Dec;22(6):823-36
11754989
Lancet Neurol. 2002 Sep;1(5):279-84
12849425
Exp Brain Res. 2000 Sep;134(1):58-65
11026726
J Neurosci. 1999 Feb 1;19(3):940-7
9920657
Neurobiol Aging. 2003 Mar-Apr;24(2):321-31
12498966
J Neurosci Res. 1998 Oct 1;54(1):1-6
9778144
Histopathology. 1993 Jun;22(6):515-25
8354484
Curr Opin Neurol. 2009 Jun;22(3):308-14
19359988
Brain Res. 1999 Jun 5;830(2):226-36
10366679
Curr Drug Targets. 2010 Apr;11(4):506-17
20015011
Neurosci Lett. 1999 Jan 15;259(3):145-8
10025579
J Alzheimers Dis. 2010;19(1):355-61
20061650
J Neurosci. 2000 Jan 15;20(2):558-67
10632585
Glia. 2001 Jul;35(1):72-9
11424194
J Neurosci. 2007 Mar 21;27(12):3057-63
17376966
Neurobiol Aging. 1997 Jul-Aug;18(4):415-21
9330973
Mol Biol Cell. 2007 Apr;18(4):1490-6
17314396
Arch Neurol. 2008 Jul;65(7):896-905
18474729
J Alzheimers Dis. 2010;19(1):363-72
20061651
Glia. 2005 Aug 1;51(2):111-20
15789431
Neuroepidemiology. 2002 Mar-Apr;21(2):81-6
11901277
Neurology. 2004 Jan 13;62(1):66-71
14718699